Round Table: Leveraging Real-World Evidence to Shape Early Biomarker & Precision Medicine Strategies in Europe
- How RWE helps us understand “who the patients really are”: Practical ways teams use real-world data to identify the right patient groups early on, even before trials begin
- Using early insights to shape better clinical trials: How early signals from real-world and genomic data can guide inclusion criteria, endpoints, and trial design decisions